IL17A and fungal infectious disease: However, even in cases with an intact IL-17 response, the local effects of an IFN-γ/STAT1–driven interferonopathy alone can be enough to promote mucocutaneous fungal infections by impairing the integrity of the epithelial barrier (42, 57, 59).